[18F]PBR111 and Microglial Activation in Multiple Sclerosis
Clinical trial NCT01428505 · TERMINATED
Trial details
- NCT number
- NCT01428505
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.